目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Cardiovascular Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of Obesity
3.2.1.2 Rising Consumption of Tobacco
3.2.1.3 Increasing Incidence of Coronary Artery Diseases (CAD)
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Regulatory Requirements Delaying the Approval of Cardiac Devices
3.2.3 Market Opportunities
3.2.3.1 Growth Potential in Emerging Economies
3.2.3.2 Growing Availability of Efficient Devices
3.3 Porter’s Five Forces Analysis
3.3.1 Supplier Power
3.3.2 Buyer Power
3.3.3 Competitive Rivalry
3.3.4 Threat from Substitutes
3.3.5 Threat of New Entrants
3.4 PESTLE Analysis
3.5 COVID-19 Impact Analysis

4 Cardiovascular Devices Market Analysis by Disease
4.1 Key Findings
4.2 Disease Segment: Market Attractiveness Index
4.3 Cardiovascular Devices Market Size Estimation and Forecast by Disease
4.4 Hypertension
4.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Atrial Fibrillation
4.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Chronic Ischemic Heart Diseases
4.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Stroke
4.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Heart Failure
4.8.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Other Diseases
4.9.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.9.2 Market Share by Region, 2023 & 2033 (%)

5 Cardiovascular Devices Market Analysis by Type
5.1 Key Findings
5.2 Type Segment: Market Attractiveness Index
5.3 Cardiovascular Devices Market Size Estimation and Forecast by Type
5.4 Diagnostic and Monitoring Devices
5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Therapeutic and Surgical Devices
5.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Cardiovascular Devices Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Cardiovascular Devices Market Size Estimation and Forecast by End-users
6.4 Hospitals
6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Diagnostic Laboratories
6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Home and Ambulatory Care
6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Research Laboratories
6.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Cardiovascular Devices Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America Cardiovascular Devices Market Analysis
8.1 Key Findings
8.2 North America Cardiovascular Devices Market Attractiveness Index
8.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
8.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
8.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
8.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
8.8 U.S. Cardiovascular Devices Market Analysis
8.9 Canada Cardiovascular Devices Market Analysis

9 Europe Cardiovascular Devices Market Analysis
9.1 Key Findings
9.2 Europe Cardiovascular Devices Market Attractiveness Index
9.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
9.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
9.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
9.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
9.8 Germany Cardiovascular Devices Market Analysis
9.9 UK Cardiovascular Devices Market Analysis
9.10 France Cardiovascular Devices Market Analysis
9.11 Italy Cardiovascular Devices Market Analysis
9.12 Spain Cardiovascular Devices Market Analysis
9.13 Russia Cardiovascular Devices Market Analysis
9.14 Rest of Europe Cardiovascular Devices Market Analysis

10 Asia Pacific Cardiovascular Devices Market Analysis
10.1 Key Findings
10.2 Asia Pacific Cardiovascular Devices Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
10.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
10.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
10.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
10.8 Japan Cardiovascular Devices Market Analysis
10.9 China Cardiovascular Devices Market Analysis
10.10 India Cardiovascular Devices Market Analysis
10.11 Australia Cardiovascular Devices Market Analysis
10.12 South Korea Cardiovascular Devices Market Analysis
10.13 Rest of Asia Pacific Cardiovascular Devices Market Analysis

11 Latin America Cardiovascular Devices Market Analysis
11.1 Key Findings
11.2 Latin America Cardiovascular Devices Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
11.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
11.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
11.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
11.8 Brazil Cardiovascular Devices Market Analysis
11.9 Mexico Cardiovascular Devices Market Analysis
11.10 Rest of Latin America Cardiovascular Devices Market Analysis

12 MEA Cardiovascular Devices Market Analysis
12.1 Key Findings
12.2 MEA Cardiovascular Devices Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
12.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
12.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
12.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
12.8 GCC Cardiovascular Devices Market Analysis
12.9 South Africa Cardiovascular Devices Market Analysis
12.10 Rest of MEA Cardiovascular Devices Market Analysis

13 Company Profiles
13.1 Abbott
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2017-2021
13.1.3.2 Regional Market Shares, 2021
13.1.3.3 Gross Profit, 2017-2021
13.1.3.4 R&D, 2017-2021
13.1.4 Product Benchmarking
13.1.5 Strategic Outlook
13.2 B. Braun SE
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2017-2021
13.2.3.2 Regional Market Shares, 2021
13.2.3.3 Gross Profit, 2017-2021
13.2.3.4 R&D, 2017-2021
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 Boston Scientific Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Market Shares, 2021
13.3.3.3 Gross Profit, 2017-2021
13.3.3.4 R&D, 2017-2021
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Becton, Dickinson and Company (BD)
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Market Shares, 2021
13.4.3.3 Gross Profit, 2017-2021
13.4.3.4 R&D, 2017-2021
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Cardinal Health
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.3.2 Regional Market Shares, 2021
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Cook Group
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Strategic Outlook
13.7 Medtronic
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Regional Market Shares, 2021
13.7.3.3 R&D, 2017-2021
13.7.4 Product Benchmarking
13.7.5 Strategic Outlook
13.8 Terumo Corporation
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.3.2 Regional Market Shares, 2022
13.8.3.3 Gross Profit, 2017-2021
13.8.4 Product Benchmarking
13.8.5 Strategic Outlook
13.9 Koninklijke Philips N.V.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Market Shares, 2021
13.9.3.3 Gross Profit, 2017-2021
13.9.3.4 R&D, 2017-2021
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 BIOTRONIK SE & CO. KG
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.10.4 Strategic Outlook
13.11 W. L. Gore & Associates, Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Strategic Outlook
13.12 GE Healthcare
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.3.2 Regional Market Shares, 2021
13.12.3.3 Gross Profit, 2017-2021
13.12.3.4 R&D, 2018-2021
13.12.4 Product Benchmarking
13.12.5 Strategic Outlook
13.13 Canon Medical Systems Corporation
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 Regional Market Shares, 2021
13.13.3.3 Gross Profit, 2017-2021
13.13.3.4 R&D, 2017-2021
13.13.4 Product Benchmarking
13.13.5 Strategic Outlook
13.14 Johnson & Johnson Services, Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Gross Profit, 2017-2021
13.14.3.3 R&D, 2017-2021
13.14.4 Product Benchmarking
13.14.5 Strategic Outlook
13.15 Siemens Healthcare GmbH
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Regional Market Shares, 2021
13.15.3.3 R&D, 2017-2021
13.15.4 Product Benchmarking
13.15.5 Strategic Outlook
13.16 Edwards Lifesciences Corporation
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.3.2 Gross Profit, 2017-2021
13.16.3.3 R&D, 2017-2021
13.16.4 Product Benchmarking
13.16.5 Strategic Outlook
13.17 LivaNova PLC
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Gross Profit, 2017-2021
13.17.3.3 R&D, 2017-2021
13.17.4 Product Benchmarking
13.17.5 Strategic Outlook

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 Cardiovascular Devices Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 7 Hypertension Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 8 Atrial Fibrillation Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 9 Chronic Ischemic Heart Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 10 Stroke Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 11 Heart Failure Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 12 Other Diseases Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 13 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 14 Diagnostic and Monitoring Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 15 Therapeutic and Surgical Devices Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 16 Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 17 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 18 Diagnostic Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 19 Home and Ambulatory Care Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 20 Research Laboratories Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 21 Cardiovascular Devices Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 22 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 23 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 24 North America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 25 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 26 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 27 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 28 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 29 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 30 Europe Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 31 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 32 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 33 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 34 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 35 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 36 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 37 Rest of Euorpe Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 38 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 39 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 40 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 41 Asia Pacific Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 42 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 43 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 44 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 45 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 46 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 47 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 48 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 49 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 50 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 51 Latin America Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 52 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 53 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 54 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 55 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 56 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 57 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 58 MEA Cardiovascular Devices Market Forecast by End-user, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 59 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 60 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 61 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 62 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Abbott: Product Benchmarking
Table 64 Abbott Laboratories: Strategic Outlook
Table 65 B. Braun SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 B. Braun SE: Product Benchmarking
Table 67 B. Braun SE: Strategic Outlook
Table 68 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Boston Scientific Corporation: Product Benchmarking
Table 70 Boston Scientific Corporation: Strategic Outlook
Table 71 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 BD: Product Benchmarking
Table 73 BD: Strategic Outlook
Table 74 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Cardinal Health: Product Benchmarking
Table 76 Cardinal Health, Inc.: Strategic Outlook
Table 77 Cook Group: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Cook Group: Product Benchmarking
Table 79 Cook Group: Strategic Outlook
Table 80 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Medtronic: Product Benchmarking
Table 82 Medtronic: Strategic Outlook
Table 83 Terumo Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Terumo Corporation: Product Benchmarking
Table 85 Terumo Corporation: Strategic Outlook
Table 86 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Koninklijke Philips N.V.: Product Benchmarking
Table 88 Koninklijke Philips N.V.: Strategic Outlook
Table 89 Biotronik: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Biotronik: Product Benchmarking
Table 91 Biotronik: Strategic Outlook
Table 92 W. L. Gore & Associates, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 W. L. Gore & Associates, Inc.: Product Benchmarking
Table 94 W. L. Gore & Associates, Inc.: Strategic Outlook
Table 95 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 GE Healthcare: Product Benchmarking
Table 97 GE Healthcare: Strategic Outlook
Table 98 Canon Medical Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Canon Medical Systems Corporation: Product Benchmarking
Table 100 Canon Medical Systems Corporation: Strategic Outlook
Table 101 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 103 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 104 Siemens Healthcare GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Siemens: Product Benchmarking
Table 106 Siemens: Strategic Outlook
Table 107 Edwards Lifesciences Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Edwards Lifesciences Corporation: Product Benchmarking
Table 109 Edwards Lifesciences Corporation: Strategic Outlook
Table 110 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 LivaNova PLC: Product Benchmarking
Table 112 LivaNova PLC: Strategic Outlook
?

List of Figures
Figure 1 Cardiovascular Devices Market Segmentation
Figure 2 Cardiovascular Devices Market by Disease: Market Attractiveness Index
Figure 3 Cardiovascular Devices Market by Type: Market Attractiveness Index
Figure 4 Cardiovascular Devices Market by End-users: Market Attractiveness Index
Figure 5 Cardiovascular Devices Market Attractiveness Index by Region
Figure 6 Cardiovascular Devices Market: Market Dynamics
Figure 7 Number of Overweight & Obese People Globally (Billion)
Figure 8 Number of Diabetic People Globally (Million)
Figure 9 Diabetes Around the World, 2021
Figure 10 Cardiovascular Devices Market: PESTLE Analysis
Figure 11 COVID Impact Analysis: Cardiovascular Devices Market Recovery Scenarios
Figure 12 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 13 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 14 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 15 Cardiovascular Devices Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 16 Cardiovascular Devices Market Attractiveness Index by Disease
Figure 17 Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 18 Cardiovascular Devices Market Share Forecast by Disease, 2023, 2028, 2033 (%)
Figure 19 Hypertension Market Forecast by Region, 2023-2033 (US$ billion)
Figure 20 Hypertension Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Atrial Fibrillation Market Forecast by Region, 2023-2033 (US$ billion)
Figure 22 Atrial Fibrillation Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Chronic Ischemic Heart Diseases Market Forecast by Region, 2023-2033 (US$ billion)
Figure 24 Chronic Ischemic Heart Diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Stroke Market Forecast by Region, 2023-2033 (US$ billion)
Figure 26 Stroke Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Heart Failure Market Forecast by Region, 2023-2033 (US$ billion)
Figure 28 Heart Failure Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Other Diseases Market Forecast by Region, 2023-2033 (US$ billion)
Figure 30 Other Diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Cardiovascular Devices Market Attractiveness Index by Disease
Figure 32 Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 33 Cardiovascular Devices Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 34 Diagnostic and Monitoring Devices Market Forecast by Region, 2023-2033 (US$ billion)
Figure 35 Diagnostic and Monitoring Devices Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Therapeutic and Surgical Devices Market Forecast by Region, 2023-2033 (US$ billion)
Figure 37 Therapeutic and Surgical Devices Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Cardiovascular Devices Market Attractiveness Index by End-users
Figure 39 Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 40 Cardiovascular Devices Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 41 Hospitals Market Forecast by Region, 2023-2033 (US$ billion)
Figure 42 Hospitals Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Diagnostic Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
Figure 44 Diagnostic Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Home and Ambulatory Care Market Forecast by Region, 2023-2033 (US$ billion)
Figure 46 Home and Ambulatory Care Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Research Laboratories Market Forecast by Region, 2023-2033 (US$ billion)
Figure 48 Research Laboratories Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Cardiovascular Devices Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 50 Cardiovascular Devices Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 51 Cardiovascular Devices Market by Region, 2023-2033 (US$ bn)
Figure 52 North America Cardiovascular Devices Market Attractiveness Index
Figure 53 North America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 54 North America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 55 North America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 56 North America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 57 North America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 58 North America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 59 North America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 60 North America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 61 North America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 62 U.S. Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 63 Canada Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 64 Europe Cardiovascular Devices Market Attractiveness Index
Figure 65 Europe Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 66 Europe Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 67 Europe Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 68 Europe Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 69 Europe Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 70 Europe Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 71 Europe Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 72 Europe Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 73 Europe Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 74 Germany Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 75 UK Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 76 France Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 77 Italy Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 78 Spain Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 79 Russia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 80 Rest of Europe Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 81 Asia Pacific Cardiovascular Devices Market Attractiveness Index
Figure 82 Asia Pacific Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 83 Asia Pacific Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 84 Asia Pacific Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 85 Asia Pacific Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 86 Asia Pacific Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 87 Asia Pacific Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 88 Asia Pacific Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 89 Asia Pacific Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 90 Asia Pacific Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 91 Japan Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 92 China Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 93 India Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 94 Australia Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 95 South Korea Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 96 Rest of Asia Pacific Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 97 Latin America Cardiovascular Devices Market Attractiveness Index
Figure 98 Latin America Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 99 Latin America Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 100 Latin America Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 101 Latin America Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 102 Latin America Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 103 Latin America Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 104 Latin America Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 105 Latin America Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 106 Latin America Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 107 Brazil Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 108 Mexico Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 109 Rest of Latin America Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 110 MEA Cardiovascular Devices Market Attractiveness Index
Figure 111 MEA Cardiovascular Devices Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 112 MEA Cardiovascular Devices Market Forecast by Country, 2023-2033 (US$ billion)
Figure 113 MEA Cardiovascular Devices Market Share Forecast by Country, 2023 & 2033 (%)
Figure 114 MEA Cardiovascular Devices Market Forecast by Disease, 2023-2033 (US$ billion)
Figure 115 MEA Cardiovascular Devices Market Share Forecast by Disease, 2023 & 2033 (%)
Figure 116 MEA Cardiovascular Devices Market Forecast by Type, 2023-2033 (US$ billion)
Figure 117 MEA Cardiovascular Devices Market Share Forecast by Type, 2023 & 2033 (%)
Figure 118 MEA Cardiovascular Devices Market Forecast by End-users, 2023-2033 (US$ billion)
Figure 119 MEA Cardiovascular Devices Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 120 GCC Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 121 South Africa Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 122 Rest of MEA Cardiovascular Devices Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 123 Abbott: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 124 Abbott: Regional Market Shares, 2021
Figure 125 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 126 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 127 B. Braun SE: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 128 B. Braun SE: Regional Market Shares, 2021
Figure 129 B. Braun SE: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 130 B. Braun SE: R&D, 2017-2021 (US$ million, AGR%)
Figure 131 Boston Scientific Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 132 Boston Scientific Corporation: Regional Market Shares, 2021
Figure 133 Boston Scientific Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 134 Boston Scientific Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 135 BD: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 136 BD: Regional Market Shares, 2021
Figure 137 BD: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 138 BD: R&D, 2017-2021 (US$ million, AGR%)
Figure 139 Cardinal Health: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 140 Cardinal Health: Regional Market Shares, 2021
Figure 141 Medtronic: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 142 Medtronic: Regional Market Shares, 2021
Figure 143 Medtronic: R&D, 2017-2021 (US$ million, AGR%)
Figure 144 Terumo Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 Terumo Corporation: Regional Market Shares, 2022
Figure 146 Terumo Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 147 Koninklijke Philips N.V.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 Koninklijke Philips N.V.: Regional Market Shares, 2021
Figure 149 Koninklijke Philips N.V.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 150 Koninklijke Philips N.V.: R&D, 2017-2021 (US$ million, AGR%)
Figure 151 GE Healthcare: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 152 GE Healthcare: Regional Market Shares, 2021
Figure 153 GE Healthcare: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 154 GE Healthcare: R&D, 2018-2021 (US$ million, AGR%)
Figure 155 Canon Medical Systems Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 156 Canon Medical Systems Corporation: Regional Market Shares, 2021
Figure 157 Canon Medical Systems Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 158 Canon Medical Systems Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 159 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 161 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 162 Siemens: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 163 Siemens: Regional Market Shares, 2021
Figure 164 Siemens: R&D, 2017-2021 (US$ million, AGR%)
Figure 165 Edwards Lifesciences Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 166 Edwards Lifesciences Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 167 Edwards Lifesciences Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 168 LivaNova PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 169 LivaNova PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 170 LivaNova PLC: R&D, 2017-2021 (US$ million, AGR%)